Atraumatic Zirconia Abutment Versus Customized Composite Healing Abutment in Maxilla or Mandible.

Sponsor
SIA Adenta (Other)
Overall Status
Recruiting
CT.gov ID
NCT05748379
Collaborator
(none)
44
1
2
24.3
1.8

Study Details

Study Description

Brief Summary

40 patients are included in the study, 20 patients in group 1 (=closure with composite material shaper; test group) and 20 patients in group 2 (=closure with custom-made zirconia oxide abutment; control group).

Randomisation envelopes will be used for randomisation. Device under study: Straumann BLX, Roxolid® , SLActive® dental implants with a diameter of 3.5, 3.75, 4, 4.5 mm are used.

Allogenic bone botiss maxgraft® cortical granules are used as graft material.

Inclusion criteria:
  1. Males and females at least 18 years of age or older.

  2. One implant per patient.

  3. Prior to any study-related activity, the subject must voluntarily sign informed consent, be willing and able to attend scheduled follow-up visits, and agree to the collection and analysis of pseudonymised data.

  4. Lateral individual teeth (premolars and molars).

  5. Class I extraction socket (intact buccal wall) or class II (1/3 of buccal wall).

  6. The gingival contour of the tooth to be extracted - without recession.

  7. Adjacent anterior teeth have no periodontal loss.

  8. There are no implants in the adjacent teeth.

  9. Non-traumatic tooth extraction, which results in intact walls of the socket.

Exclusion criteria:
  1. Deep occlusion (severe, class II).

  2. The patient smokes a lot (more than 10 cigarettes per day).

  3. Systemic disease (osteoporosis).

  4. No initial stability has been achieved after the implant insertion procedure.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Kompozite closure
  • Procedure: Individual abutment
N/A

Detailed Description

General Notes

40 patients are included in the study, 20 patients in group 1 (=closure with composite material shaper; test group) and 20 patients in group 2 (=closure with custom-made zirconia oxide abutment; control group).

Randomisation envelopes will be used for randomisation. Device under study: Straumann BLX, Roxolid® , SLActive® dental implants with a diameter of 3.5, 3.75, 4, 4.5 mm are used.

Allogenic bone botiss maxgraft® cortical granules are used as graft material.

Inclusion criteria:
  1. Males and females at least 18 years of age or older.

  2. One implant per patient.

  3. Prior to any study-related activity, the subject must voluntarily sign informed consent, be willing and able to attend scheduled follow-up visits, and agree to the collection and analysis of pseudonymised data.

  4. Lateral individual teeth (premolars and molars).

  5. Class I extraction socket (intact buccal wall) or class II (1/3 of buccal wall).

  6. The gingival contour of the tooth to be extracted - without recession.

  7. Adjacent anterior teeth have no periodontal loss.

  8. There are no implants in the adjacent teeth.

  9. Non-traumatic tooth extraction, which results in intact walls of the socket.

Exclusion criteria:
  1. Deep occlusion (severe, class II).

  2. The patient smokes a lot (more than 10 cigarettes per day).

  3. Systemic disease (osteoporosis).

  4. No initial stability has been achieved after the implant insertion procedure. 4.2. Surgical Procedures and Recovery Phase (see Annexes No. 1 and 2)

Group 1. Immediate implant placement and temporary closure of tapered implants with a custom-made composite shaper after tooth extraction with bone augmentation by using allogeneic bone.

  1. Non-traumatic extraction.

  2. Palatal position of tapered implant for premolars and centred position for molars (more commonly - in the septum) 3-4 mm below the buccal gum line or 1-2 mm below the bony protuberance.

  3. For premolars, the implant is placed palatally 2-3 mm to the buccal bone wall, for molars 2-3 mm to the buccal and lingual wall.

  4. Implant insertion.

  5. "Jump distance" sealing with allogeneic bone.

  6. Temporary closure with a composite shaper.

  7. Cone beam computed tomography with Carestream machine.

  8. Taking a photo.

  9. Scan with 3Shape TRIOS4 scanner.

After 3 months, a cone beam computed tomography is performed to evaluate changes in the crestal bone, the temporary restoration is screwed off and the presence/absence of bleeding is recorded. A digital impression is taken for a zirconium oxide crown made on Ti base and to assess soft tissue changes.

The change in the buccal vertical bone level will be measured as the difference between the former and the new vertical distance from implant platform to the buccal alveolar crest.

While the change in the buccal horizontal bone dimension will be measured as the difference between the former and the new horizontal distance between the implant and the outer surface of the buccal plate. Both measurements will be taken using CBCT, one immediately after the surgery and the other one 3 month later.

Intraoral scans with 3Shape Trios4 dental scanner will be taken to compare soft tissue stability. Measurements will be taken before, immediately after the surgery and 3 month later. By using STL files it will be possible to compare soft tissue stability.

Group 2. Immediate implant placement and temporary closure of tapered implant with a custom-made zirconium oxide abutment after tooth extraction with bone augmentation by using allogeneic bone.

  1. Non-traumatic extraction.

  2. Palatal position of tapered implant for premolars and centred position for molars (more commonly - in the septum) 3-4 mm below the buccal gum line or 1-2 mm below the bony protuberance.

  3. For premolars, the implant is placed palatally 2-3 mm to the buccal bone wall, for molars 2-3 mm to the buccal and lingual wall.

  4. Implant insertion.

  5. "Jump distance" sealing with allogeneic bone.

  6. Closure with a zirconium oxide abutment.

  7. Cone beam computed tomography with Carestream machine.

  8. Taking a photo.

  9. Scan with 3Shape TRIOS4 scanner.

After 3 months, a cone beam computed tomography is performed to evaluate changes in the crestal bone, the custom-made abutment is screwed off and the presence/absence of bleeding is recorded. A digital impression is taken for a zirconium oxide crown and to assess soft tissue changes.

The change in the buccal vertical bone level will be measured as the difference between the former and the new vertical distance from implant platform to the buccal alveolar crest.

While the change in the buccal horizontal bone dimension will be measured as the difference between the former and the new horizontal distance between the implant and the outer surface of the buccal plate. Both measurements will be taken using CBCT, one immediately after the surgery and the other one 3 month later.

Intraoral scans with 3Shape Trios4 dental scanner will be taken to compare soft tissue stability. Measurements will be taken before, immediately after the surgery and 3 month later. By using STL files it will be possible to compare soft tissue stability.

Evaluation Phase

T1 (Basic): After the performance of final restoration: X-ray, photograph, scan, PD, BOP, RI.

T2: Follow-up after 3 months: X-ray, photograph, scan, PD, BOP, RI. T3: Follow-up after a year: X-ray, photograph, scan, PD, BOP, RI.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
44 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Masking Description:
Each patient has their individual ID number
Primary Purpose:
Diagnostic
Official Title:
Closure of a Guided Immediate Implant Placed in the Extraction Socket With Bone Augmentation in the Lateral Area of the Maxilla or Mandible, With a Temporary Composite Abutment vs With a Custom-made Zirconium Oxide Abutment.
Actual Study Start Date :
Nov 30, 2022
Actual Primary Completion Date :
Dec 10, 2022
Anticipated Study Completion Date :
Dec 10, 2024

Arms and Interventions

Arm Intervention/Treatment
Other: Kompozite closure

Immediate implant placement and temporary closure of tapered implants with a custom-made composite shaper after tooth extraction with bone augmentation by using allogeneic bone.

Procedure: Kompozite closure
Immediate implant placement and temporary closure of tapered implants with a custom-made composite shaper.

Other: Individual abutment

Immediate implant placement and temporary closure of tapered implant with a custom-made zirconium oxide abutment after tooth extraction with bone augmentation by using allogeneic bone.

Procedure: Individual abutment
Immediate implant placement and temporary closure of tapered implant with a custom-made zirconium oxide abutment.

Outcome Measures

Primary Outcome Measures

  1. Stability of crestal bone [Before surgery, immediately after surgery, 3 moth, 1 year follow up]

    To compare crystal bone stability CBCT will be taken before surgery. , immediately after surgery, after 3 month and a follow up after 1 year. The change in the buccal vertical bone level will be measured as the difference between the former and the new vertical distance from implant platform to the buccal alveolar crest. While the change in the buccal horizontal bone dimension will be measured as the difference between the former and the new horizontal distance between the implant and the outer surface of the buccal plate. Both measurements will be taken using CBCT, one immediately after the surgery and the other one 3 month later

  2. The changes of stability of soft tissue [Before surgery, immediately after surgery, 3 month, 1 year follow up]

    Recession (REC) state of the gingival/mucosa border - registered by means of a periodontal probe from the incisal edge to the border of the medial, zenith and distal zones. There are taken scans with 3Shape Trios4 before surgery, immediately after, then 3 month and 1 year follow up to compare soft tissue stability

  3. The change of position of implant using surgical guide [Before surgery and immediately after surgery]

    To compare implant position accuracy using surgical guide, the following two things will be compared: DICOM after the surgery witch contains information on the implant position in the bone and the STL file witch contains information on implant position before the surgery. There are taken cone beam computer tomography before and immediately after surgery, then 3 month and 1 year follow up.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Males and females at least 18 years of age or older.

  2. One implant per patient.

  3. Prior to any study-related activity, the subject must voluntarily sign informed consent, be willing and able to attend scheduled follow-up visits, and agree to the collection and analysis of pseudonymised data.

  4. Lateral individual teeth (premolars and molars).

  5. Class I extraction socket (intact buccal wall) or class II (1/3 of buccal wall).

  6. The gingival contour of the tooth to be extracted - without recession.

  7. Adjacent anterior teeth have no periodontal loss.

  8. There are no implants in the adjacent teeth.

  9. Non-traumatic tooth extraction, which results in intact walls of the socket.

Exclusion Criteria:
  1. Deep occlusion (severe, class II).

  2. The patient smokes a lot (more than 10 cigarettes per day).

  3. Systemic disease (osteoporosis).

  4. No initial stability has been achieved after the implant insertion procedure

Contacts and Locations

Locations

Site City State Country Postal Code
1 Adenta Riga Latvija Latvia LV-1045

Sponsors and Collaborators

  • SIA Adenta

Investigators

  • Study Director: Ģirts Šalms, Asoc.prof, Riga Stradiņš University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Vitālijs Gnusins, Doctor of dental Surgery, SIA Adenta
ClinicalTrials.gov Identifier:
NCT05748379
Other Study ID Numbers:
  • SIAAdenta
First Posted:
Feb 28, 2023
Last Update Posted:
Feb 28, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Feb 28, 2023